ストックスクリーナーアプリを入手
126.61
0.45%
-0.57
アフターアワーズ：
126.86
0.25
+0.20%
Abbott Laboratories (ABT) 最新ニュース
Abbott Laboratories (ABT): Evaluating Its Valuation Following Recent Share Price Pullback - simplywall.st
How Abbott Laboratories stock reacts to inflationary pressuresWeekly Risk Report & AI Forecasted Stock Moves - Fundação Cultural do Pará
Data supports Abbott Tendyne mitral valve replacement - MassDevice
Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You? - The Motley Fool
Technical signs of recovery in Abbott LaboratoriesMarket Volume Summary & Target Return Focused Stock Picks - newser.com
What makes Abbott Laboratories stock attractive to growth fundsM&A Rumor & Risk Adjusted Buy and Sell Alerts - Fundação Cultural do Pará
Abbott Laboratories, facing hundreds of lawsuits over safety of formula for premature babies, notches a win in federal court - Slipcase
Abbott’s New Study on Dydrogesterone: A Potential Game-Changer for Endometriosis Pain - TipRanks
Is Abbott Laboratories (Common Stock) (ABL0) stock a buy for dividend portfoliosJuly 2025 Price Swings & Precise Buy Zone Identification - Fundação Cultural do Pará
Abbott Laboratories wins Illinois court case on NEC baby formula claims - Global Food Industry News
Using R and stats models for Abbott Laboratories forecastingWeekly Market Summary & Real-Time Volume Triggers - newser.com
What is the fair value estimate for Abbott Laboratories (ABL) stock in 2025Trade Risk Report & Smart Swing Trading Techniques - newser.com
Will a bounce in Abbott Laboratories offer an exitSwing Trade & High Conviction Investment Ideas - newser.com
Is Abbott Laboratories stock a buy in volatile marketsGap Up & Verified Stock Trade Ideas - newser.com
Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum - MSN
Will Abbott Laboratories (ABL) stock maintain strong growthStop Loss & Verified Momentum Stock Watchlist - newser.com
Abbott Laboratories wins lawsuit over safety of baby formula - Chicago Tribune
Abbott Wins Third Bellwether as Judge Rules Human-Milk Alternative ‘Unfeasible’ - USA Herald
Abbott Wins Third Bellwether In Cow Milk Baby Formula MDL - Law360
Abbott wins third of four 'bellwether' infant formula lawsuits - Crain's Chicago Business
Protein Bar Market Size, Share, and Growth 2025-2035 | Abbott - openPR.com
Abbott Can't Expand Glucose Monitor Sales Ban At UPC - Law360
Abbott Laboratories (ABT): Exploring Valuation After a Recent Share Price Pullback - Yahoo Finance
Meet RFK’s Corporate Underlings - The American Prospect
Is Abbott Laboratories stock dividend growth reliableJuly 2025 Catalysts & Smart Swing Trading Alerts - newser.com
How Abbott’s Innovative Partnerships Are Shaping Its 2025 Valuation Amid 12.8% YTD Gain - simplywall.st
United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall - GlobeNewswire
1 Safe-and-Steady Stock with Exciting Potential and 2 We Question - The Globe and Mail
Synlait Milk Confirms Investment Regulator's Approval for Abbott's Acquisition of North Island Assets - MarketScreener
A Look Into Abbott Laboratories Inc's Price Over Earnings - Sahm
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock - Yahoo Finance
The 5 Most Interesting Analyst Questions From Abbott Laboratories’s Q3 Earnings Call - Yahoo Finance
How Abbott Laboratories stock compares to growth peersMarket Movement Recap & Free Weekly Watchlist of Top Performers - newser.com
Can Abbott Laboratories (Common Stock) (ABL0) stock sustain margin levelsGap Down & Entry and Exit Point Strategies - newser.com
Is Abbott Laboratories (ABL) stock cheap by valuation metricsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com
Is Abbott Laboratories showing signs of accumulationMarket Movement Recap & Expert Approved Momentum Ideas - newser.com
Volatility clustering patterns for Abbott LaboratoriesPortfolio Risk Report & Real-Time Market Trend Scan - newser.com
Walmart to sell Abbott's CGM in US 1st - Fierce Biotech
Abbott - Boston Athletic Association
Daiwa Securities Adjusts Abbott Laboratories Price Target to $136 From $134, Maintains Outperform Rating - MarketScreener
Walmart to be first US retailer to sell Abbott's continuous glucose monitor - Reuters
Walmart (WMT) Expands Health Offerings with Abbott's Lingo Gluco - GuruFocus
Functional Foods Forecast and Company Analysis Report 2025: A $678.32 Billion Market by 2033 Featuring Abbott, Amway, BASF, Cargill, Clif Ba, Danone, General Mills, Kellogg, Kerry, Nestle - Yahoo Finance
Walmart said to become first physical retailer to sell Abbott’s OTC glucose monitor, Lingo - Seeking Alpha
Walmart to be first US retailer to sell Abbott's continuous glucose monitor, Axios reports - TradingView
How to read the order book for Abbott Laboratories2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience - Insider Monkey
Bringing Biomarkers to the Bedside: The Clinical Promise of Abbott’s TBI Test - NeurologyLive
Did Mixed Segment Results and Narrowed Guidance Just Shift Abbott Laboratories' (ABT) Investment Narrative? - Yahoo Finance
Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings - TradingView
Will Abbott Laboratories price bounce be sustainableTrade Entry Report & Step-by-Step Swing Trade Plans - newser.com
Why analysts recommend Abbott Laboratories (ABL) stockPortfolio Return Summary & AI Powered Trade Plan Recommendations - newser.com
Is Abbott Laboratories (ABL) stock a safe buy pre earningsTrade Exit Report & Weekly Top Gainers Trade List - Trung tâm Dự báo KTTV quốc gia
1.43%
1.70%
大文字化:
|
ボリューム (24 時間):